These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 6107767)

  • 1. Low-dose captopril in chronic heart failure: acute haemodynamic effects and long-term treatment.
    Sharpe DN; Douglas JE; Coxon RJ; Long B
    Lancet; 1980 Nov; 2(8205):1154-7. PubMed ID: 6107767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation.
    Borchert T; Hess A; Lukačević M; Ross TL; Bengel FM; Thackeray JT
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(7):1757-1768. PubMed ID: 32125488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heart failure program on cardiovascular drug utilization and dosage in patients with chronic heart failure.
    Ramahi TM; Longo MD; Rohlfs K; Sheynberg N
    Clin Cardiol; 2000 Dec; 23(12):909-14. PubMed ID: 11129677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in chronic heart failure: cilazapril and captopril versus placebo. Cilazapril-Captopril Multicentre Group.
    Bulpitt CJ; Fletcher AE; Dössegger L; Neiss A; Nielsen T; Viergutz S
    Heart; 1998 Jun; 79(6):593-8. PubMed ID: 10078088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of captopril on renal function in patients with congestive heart failure.
    Pierpont GL; Francis GS; Cohn JN
    Br Heart J; 1981 Nov; 46(5):522-7. PubMed ID: 7032555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
    Dahlström U; Karlberg BE
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
    Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
    Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting enzyme inhibitors in hypertension and heart failure.
    Dargie HJ; Ball SG; Atkinson AB; Robertson JI
    Br Heart J; 1983 Apr; 49(4):305-8. PubMed ID: 6299314
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
    Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
    Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Captopril in congestive heart failure (author's transl)].
    Liebau G
    Klin Wochenschr; 1982 Feb; 60(3):107-13. PubMed ID: 6210798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of captopril on plasma histamine and histamine release in vitro.
    Taylor KM; Sharpe DN
    Agents Actions; 1981 Nov; 11(5):448-53. PubMed ID: 6175193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
    Dawson JR; Canepa-Anson R; Kuan P; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-blockers and converting enzyme inhibitors.
    Rubin PC; Reid JL
    Br Med J (Clin Res Ed); 1983 Apr; 286(6372):1192-5. PubMed ID: 6132654
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous captopril treatment in patients with severe cardiac failure.
    Rademaker M; Shaw TR; Williams BC; Duncan FM; Corrie J; Eglen A; Edwards CR
    Br Heart J; 1986 Feb; 55(2):187-90. PubMed ID: 3510643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension.
    Patakas D; Georgopoulos D; Rodini H; Christaki P
    Postgrad Med J; 1988 Mar; 64(749):193-5. PubMed ID: 3050941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of heart failure. A methodological review of the literature.
    Guyatt GH
    Drugs; 1986 Dec; 32(6):538-68. PubMed ID: 3024949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
    Holt P; Najm J; Sowton E
    Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled trial of enalapril in congestive cardiac failure.
    McGrath BP; Arnolda L; Matthews PG; Jackson B; Jennings G; Kiat H; Johnston CI
    Br Heart J; 1985 Oct; 54(4):405-14. PubMed ID: 2996575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.